Table 1 Correlation between SPRYD4 expression with clinicopathological characteristics of ACC patients
Clinicopathological variables | Patients (n = 82) | SPRYD4 expression | P Value | |
|---|---|---|---|---|
High (42) | Low (40) | |||
Gender | ||||
 Male | 52 | 25 | 27 | 0.60 |
 Female | 30 | 17 | 13 | |
Age | ||||
 ≧50 | 50 | 28 | 22 | 0.39 |
 < 50 | 32 | 14 | 18 | |
CA19-9 | ||||
 ≧300 kU/L | 31 | 13 | 18 | 0.28 |
 < 300 kU/L | 51 | 29 | 22 | |
Lymphnodes metastasis | ||||
 Positive | 26 | 7 | 19 | < 0.01 |
 Negative | 56 | 35 | 21 | |
Lymphovascular invasion | ||||
 Positive | 18 | 8 | 10 | 0.70 |
 Negative | 64 | 34 | 30 | |
TNM stage | ||||
 Advanced (III & IV) | 34 | 11 | 23 | < 0.01 |
 Early (I & II) | 48 | 31 | 17 | |
Differentiation | ||||
 Poor | 29 | 10 | 19 | < 0.05 |
 Well | 53 | 32 | 21 | |